Congratulations to Prof. Dr. Mohd Basyaruddin Abdul Rahman and his colleagues for their latest publication in Cancers. This review systemically outlined and meta-analyzed the Afatinib efficacy in the treatment of non-small cell lung cancer (NSCLC) and recurrent/metastatic head and neck squamous cell carcinoma R/M HNSCC in terms of overall survival (OS) and progression-free survival (PFS) endpoints. Find out more at https://www.mdpi.com/2072-6694/13/4/688/htm
Date of Input: 10/03/2021 | Updated: 10/03/2021 | azah